LncRNA TTN-AS1 regulated the functions of FLSs-OA cells induced by TNF-α and IL-1β, such as oxidative stress, angiogenesis, cell proliferation and apoptosis, as well as cartilage matrix degradation, through the miR-520d-5p, and ADAMTS5 may be the target gene for its functional effects.
Abstract
Background
Synovial inflammation is involved in all stages of osteoarthritis (OA) and is a key factor in promoting the occurrence and development of OA.
Aim
To investigate the effects of lncRNA TTN-AS1 on human synovial fibroblasts.
Materials And Methods
RT-qPCR was employed to detect the expression of the long non-coding RNA TTN-AS1, miR-520d-5p, ADAMTS5, vascular endothelial growth factor (VEGF) and matrix metallopeptidase 13 (MMP13). The Enzyme-Linked Immunosorbent Assay (ELISA) method was employed to detect interleukin-6 (IL-6) and interleukin-8 (IL-8) in cell supernatants. The proliferation and apoptosis of cells were detected by the Cell Counting Kit-8 (CCK-8) method and flow cytometry, respectively. Interactions between genes were demonstrated using dual luciferase assays and Pearson correlation analysis.
Results
In the OA synovial tissue and cell model, lncRNA TTN-AS1 and ADAMTS5 were upregulated, while miR-520d-5p was downregulated. Following TNF-α and IL-1β treatment, IL-6 and IL-8 levels significantly increased in FLSs-OA. In terms of cellular function, inhibiting lncRNA TTN-AS1 could promote expression of SOD and GSH in FLSs-OA cells, while also decreasing the expression of MDA, VEGF and MMP13. Furthermore, inhibiting lncRNA TTN-AS1 could inhibit the proliferation of FLSs-OA cells and enhance their apoptosis. However, inhibiting miR-520d-5p could reverse the cellular effects produced by inhibiting lncRNA TTN-AS1 on FLSs-OA cells. In terms of mechanism, Negative regulatory relationships existed between lncRNA TTN-AS1 and miR-520d-5p, as well as between miR-520d-5p and ADAMTS5.
Conclusion
LncRNA TTN-AS1 regulated the functions of FLSs-OA cells induced by TNF-α and IL-1β, such as oxidative stress, angiogenesis, cell proliferation and apoptosis, as well as cartilage matrix degradation, through the miR-520d-5p, and ADAMTS5 may be the target gene for its functional effects.
It is suggested that lnc-DNAJC3-AS1 promotes GC progression, at least in part, through the miR-576-5p/LYPLA1 pathway, providing a potential target for GC treatment.
Zhen-Ni Sun, Ya-Sai Yao, Zhi-Jian Xu et al.· American Journal of Cancer R...· 0 citations
Under HG conditions, silencing of SNHG12 promoted cell proliferation, inhibited apoptosis, and mitigated inflammatory responses, as well as attenuated fibrosis, reflected by decreased expression of transforming growth factor-beta 1 and alpha-smooth muscle actin.
Li-Ping Dong, Pengcheng Sun, Yu-Tong Hu et al.· Molecular Biology Reports· 0 citations
FBXL19-AS1 appears to interact with and modulate miR-650, thereby affecting ITGB3 expression and potentially participating in the pathological progression of AD.
Jie Dou, Yan-Ping Zhu, Zili Du et al.· Hereditas· 0 citations
Combining standard endometriosis treatments with exosome-mediated miR-22-3p targeting of p53 could restore p53 function, induce apoptosis, and reduce disease recurrence, providing a promising therapeutic strategy for endometriosis management.
Cong-Xiang Yu, Yue-Fei Li, Ge-Le Qi et al.· Journal of Molecular Histolo...· 0 citations
It is indicated that SLC12A9-AS1 is abnormally overexpressed in CRC cells and that its knockdown attenuates malignant phenotypes, at least in part through regulation of miR-139-3p.
Shiyu Zhao, Shuai Zhang, Qiong-Feng Tan et al.· Journal of Visualized Experi...· 0 citations
OBJECTIVE
This study aimed to evaluate the potential of miR-655-3p as a diagnostic biomarker for primary osteoarthritis (OA) and to investigate its intrinsic molecular mechanisms as a means of addressing the lack of sensitive early diagnostic biomarkers and targeted anti-inflammatory therapies for this prevalent degene...